Navigation Links
Endocrine-disrupting chemicals pose cancer risk
Date:5/25/2010

BOSTON (May 25, 2010) Longtime environmental health researchers at Tufts University School of Medicine describe the carcinogenic effects of endocrine-disrupting chemicals (EDCs), ubiquitous chemicals that have hormone-like effects in the body. In a review article published online May 25 in Nature Reviews Endocrinology, the researchers express the need for more complex strategies for studying how these chemicals affect health but report that ample evidence already supports changing public health and environmental policies to protect the public from exposure to EDCs.

"The strength and breadth of existing research on the negative effects of EDCs, including bisphenol A, warrants immediate action to reduce EDC exposure, particularly among the developing fetus and women of reproductive age," said author Carlos Sonnenschein, MD, professor in the department of anatomy and cellular biology at Tufts University School of Medicine (TUSM).

"Developing embryos 'read' environmental cues as a forecast of the outside world. These cues can affect the way certain genes are expressed and in this way alter the structure and function of organs. Studies in rodents show that EDCs can cause harm at much lower levels if exposure happens during organ formation as opposed to exposures during adulthood," said author Ana Soto, MD, professor in the department of anatomy and cellular biology at TUSM.

"The evidence indicates that exposure to BPA and other EDCs may contribute to diseases that manifest during adult life, such as increased cancer rates in the industrialized world. These chemicals have also been linked to obesity, altered behavior, and infertility," continued Soto.

The researchers drew several key points from the body of observational, epidemiological, and animal research examining EDCs, emphasizing that embryos display an increased sensitivity to the chemicals. In particular, Soto and Sonnenschein focused on bisphenol A (BPA), a chemical they have spent 15 years investigating. BPA, which is found in plastic bottles, reusable food containers, and food cans, is ubiquitous in industrialized nations and is linked to cancer.

"EDCs act additively and their effects are dependent upon exposure and context, making them inherently complex to study. New mathematical modeling tools and computer simulations will provide a more precise understanding of how these chemicals interact with each other and within the body at different stages of life. That said, we already have ample evidence supporting policies that reduce exposure to EDCs, and we recommend rapid action to diminish these harmful environmental exposures," said Sonnenschein.

In previous animal studies, Soto and Sonnenschein observed that exposure to even trace levels of BPA can increase cancer risk in adulthood. The pair also collaborated in proposing the tissue organization field theory of carcinogenesis and metastasis as an alternative to the currently-held somatic mutation theory, arguing that cancer is a tissue-based disease rather than a cell-based disease as proposed by the somatic mutation theory of carcinogenesis. Both authors are also members of the cell, molecular and developmental biology program faculty at the Sackler School of Graduate Biomedical Sciences at Tufts.


'/>"/>

Contact: Siobhan Gallagher
617-636-6586
Tufts University, Health Sciences
Source:Eurekalert

Related medicine news :

1. Prenatal exposure to endocrine-disrupting chemicals linked to breast cancer
2. Alternative chemicals ease safety concerns about nonstick, repellent coatings
3. Mount Sinai finds prenatal exposure to certain chemicals affects childhood neurodevelopment
4. Poop dermatitis linked to fashionable toilet seats, harsh chemicals
5. Workplace Chemicals May Boost Breast Cancer Risk
6. Exposure to 3 classes of common chemicals may affect female development
7. Chemicals in Beauty Products Tied to Early Puberty in Girls
8. Two New Phytochemicals with Anti-Inflammatory Activity Found in Noni Fruit
9. Selenium Helped Cells Reboot After Exposure to Cancer-Causing Chemicals
10. Targeted therapy prolongs life in patients with HER2-positive breast cancer
11. New Drugs, New Combinations Fight Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: